Work

Response to Sorafenib in FLT3/ITD AML Is Depedent on Co-Occurring Mutational Profile

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127569

Authors: Katherine Tarlock, Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Jenny L. Smith, E. Anders Kolb, Alan S Gamis, Richard Aplenc, Soheil Meshinchi

Institutions: Seattle Children's Hospital, Fred Hutch Cancer Center, Harvard University, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of Southern California, Children's Oncology Group, Alfred I. duPont Hospital for Children, Children's Mercy Hospital, Children's Hospital of Philadelphia

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2991372141

Cites:

Cited by: 7

Related to: 10